JP2015506981A5 - - Google Patents

Download PDF

Info

Publication number
JP2015506981A5
JP2015506981A5 JP2014556712A JP2014556712A JP2015506981A5 JP 2015506981 A5 JP2015506981 A5 JP 2015506981A5 JP 2014556712 A JP2014556712 A JP 2014556712A JP 2014556712 A JP2014556712 A JP 2014556712A JP 2015506981 A5 JP2015506981 A5 JP 2015506981A5
Authority
JP
Japan
Prior art keywords
composition
glucose
methyl
subject
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014556712A
Other languages
English (en)
Japanese (ja)
Other versions
JP6084238B2 (ja
JP2015506981A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/025294 external-priority patent/WO2013119917A1/en
Publication of JP2015506981A publication Critical patent/JP2015506981A/ja
Publication of JP2015506981A5 publication Critical patent/JP2015506981A5/ja
Application granted granted Critical
Publication of JP6084238B2 publication Critical patent/JP6084238B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014556712A 2012-02-08 2013-02-08 下痢を処置するための材料および方法 Active JP6084238B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596480P 2012-02-08 2012-02-08
US61/596,480 2012-02-08
PCT/US2013/025294 WO2013119917A1 (en) 2012-02-08 2013-02-08 Materials and methods for treating diarrhea

Publications (3)

Publication Number Publication Date
JP2015506981A JP2015506981A (ja) 2015-03-05
JP2015506981A5 true JP2015506981A5 (enExample) 2015-04-30
JP6084238B2 JP6084238B2 (ja) 2017-02-22

Family

ID=48948047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014556712A Active JP6084238B2 (ja) 2012-02-08 2013-02-08 下痢を処置するための材料および方法

Country Status (15)

Country Link
US (4) US20140377374A1 (enExample)
EP (1) EP2812007B1 (enExample)
JP (1) JP6084238B2 (enExample)
KR (2) KR102262179B1 (enExample)
CN (1) CN104093410B (enExample)
AP (1) AP3941A (enExample)
AU (1) AU2013216871B2 (enExample)
BR (1) BR112014019350B1 (enExample)
CA (1) CA2863388C (enExample)
EA (1) EA034014B1 (enExample)
ES (1) ES2862392T3 (enExample)
HK (1) HK1204290A1 (enExample)
IN (1) IN2014DN06737A (enExample)
MX (1) MX368543B (enExample)
WO (1) WO2013119917A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2624825B1 (en) 2010-09-24 2017-06-14 University of Florida Research Foundation, Inc. Materials and methods for improving gastrointestinal function
JP6378307B2 (ja) 2013-03-11 2018-08-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 肺機能を改善するためならびに放射線誘発肺合併症の予防および／または処置のための物質および方法
BR112017010832A2 (pt) 2014-11-24 2017-12-26 Entrinsic Health Solutions Llc composições de aminoácido para o tratamento de sintomas de doença
MX2019003821A (es) 2016-10-04 2019-12-18 Univ Florida Composiciones de aminoacidos y usos de las mismas.
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA
IL298743A (en) * 2020-06-02 2023-02-01 Univ Florida Formulations and methods for treating diarrhea
WO2022006397A1 (en) * 2020-07-02 2022-01-06 University Of Florida Research Foundation, Incorporated Formulations for promoting hydration and methods of use thereof
US20240252580A1 (en) * 2021-05-28 2024-08-01 The Coca-Cola Company Amino acid hydration formulation and method of use
CN115531363B (zh) * 2021-06-30 2024-03-29 中国科学技术大学 预防、抑制或治疗轮状病毒感染的药物组合物及其用途
US11878073B1 (en) 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
JP3301646B2 (ja) * 1993-03-19 2002-07-15 シスメックス株式会社 幼若細胞測定用試薬
KR19980703876A (ko) * 1995-04-14 1998-12-05 스티븐 엘. 허스트 분산성이 개선된 분말화된 약학적 조성물
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
US20030143293A1 (en) * 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
JP2004123642A (ja) * 2002-10-04 2004-04-22 Shimizu Pharmaceutical Co Ltd 電解質組成物
DK175877B1 (da) * 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
US20050100637A1 (en) * 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
JP4811576B2 (ja) * 2005-03-31 2011-11-09 味の素株式会社 水分電解質補給飲料
JP4512013B2 (ja) * 2005-09-07 2010-07-28 和光堂株式会社 液体飲料組成物及びその製造方法
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
EP2624825B1 (en) 2010-09-24 2017-06-14 University of Florida Research Foundation, Inc. Materials and methods for improving gastrointestinal function
JP6378307B2 (ja) * 2013-03-11 2018-08-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 肺機能を改善するためならびに放射線誘発肺合併症の予防および／または処置のための物質および方法

Similar Documents

Publication Publication Date Title
JP2015506981A5 (enExample)
RU2016119746A (ru) Стабильный состав инсулина глулизин
NZ607189A (en) Materials and methods for improving gastrointestinal function
HRP20110242T1 (hr) Formulacija s fuzijskim proteinom glp-1-fc
JP2022119854A5 (enExample)
JP2015510888A5 (enExample)
HRP20210945T1 (hr) Formulacije protutijela anti-cd19
JP2016520050A5 (enExample)
JP2015527402A5 (enExample)
RU2018141173A (ru) Препарат, содержащий антитело
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
JP2011502997A5 (enExample)
RU2015139742A (ru) Селенсодержащие композиции и их применение для лечения и предотвращения заболеваний или состояний, связанных с митохондриальной дисфункцией
RU2017132877A (ru) Комбинация антагониста pd-1 и эрибулина для лечения рака
MX2014002471A (es) Combinaciones sinergicas de los inhibidores de p13k y mek.
CA3019769C (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
BRPI0607168A2 (pt) terapia de combinação parenteral, composição farmacêutica, processo para preparar uma composição farmacêutica e método de tratamento
AR062659A1 (es) Composicion de liberacion sostenida de levodopa y metodo para su uso
BRPI0314666B8 (pt) composição nutricional ou terapêutica utilizável para o tratamento de mamíferos para aumentar a atividade imune
EA201290278A1 (ru) Способ лечения сердечной недостаточности с использованием стресскопинподобных пептидов
HK1204290A1 (en) Materials and methods for treating diarrhea
JP2018516936A5 (enExample)
RU2018129077A (ru) Стабильная фармацевтическая композиция
JP2007517038A5 (enExample)
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia